Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Duvelisib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic route for Duvelisib intermediates ensures high purity and scalable production for global pharmaceutical supply chains and cost efficiency.
Patent CN118324765A reveals a novel Ir-catalyzed route for Duvelisib, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel chiral catalytic hydrogenation route for Duvelisib reduces steps and improves safety for reliable API intermediate supply.